A recent study showed that deletion of Tgfbr2 in the setting of p53 loss reduced the formation of liver tumors, suggesting that TGF-β signaling was playing a promoting role in HCC induced by the loss of p53 [16]. This evidence concerns the gene TGFBR2 and hepatocellular carcinoma.